Abstract
Discontinuation of primary prophylaxis against toxoplasma encephalitis was studied in 199 HIV-1-infected patients on antiretroviral combination treatment who had experienced a sustained increase in their CD4 count. During a follow-up of 272 person-years, no cases of toxoplasma encephalitis arose.
Publication types
-
Letter
-
Multicenter Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
AIDS-Related Opportunistic Infections / prevention & control*
-
Adult
-
Anti-HIV Agents / therapeutic use
-
Anti-Infective Agents / therapeutic use
-
CD4 Lymphocyte Count
-
Chemoprevention
-
Cohort Studies
-
Confidence Intervals
-
Encephalitis / parasitology*
-
Encephalitis / prevention & control
-
Female
-
Follow-Up Studies
-
HIV Infections* / drug therapy
-
HIV-1*
-
Humans
-
Male
-
Middle Aged
-
Prospective Studies
-
Switzerland
-
Toxoplasmosis, Cerebral / prevention & control*
Substances
-
Anti-HIV Agents
-
Anti-Infective Agents